Current Threat of Triclabendazole Resistance in Fasciola hepatica.

Author: AndersonGlenn, BeddoeTravis, ElliottTimothy P, KelleyJane M, SkucePhilip, SpithillTerry W

Paper Details 
Original Abstract of the Article :
Triclabendazole (TCBZ) is the only chemical that kills early immature and adult Fasciola hepatica (liver fluke) but widespread resistance to the drug greatly compromises fluke control in livestock and humans. The mode of action of TCBZ and mechanism(s) underlying parasite resistance to the drug are ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.pt.2016.03.002

データ提供:米国国立医学図書館(NLM)

The Growing Threat of Triclabendazole Resistance in Fasciola hepatica

Parasitic infections, like a tenacious desert weed, can be challenging to control. This research delves into the alarming issue of triclabendazole resistance in Fasciola hepatica, a liver fluke that poses a significant threat to livestock and human health. The study examines the current status of triclabendazole resistance, its global distribution, and the potential mechanisms underlying drug resistance.

Addressing Drug Resistance in Liver Fluke Infections

The study highlights the urgent need for effective management of triclabendazole resistance, emphasizing the critical role of integrated parasite management (IPM) in controlling liver fluke infections. The researchers discuss the importance of strategic approaches, including drug rotation, alternative treatment options, and environmental control measures, to minimize the development and spread of drug resistance.

A Call for Integrated Strategies

This research underscores the importance of a multi-pronged approach to combating parasitic infections. The emergence of drug resistance in Fasciola hepatica emphasizes the need for integrated parasite management strategies that go beyond relying solely on chemical treatments.

Dr.Camel's Conclusion

This research is a stark reminder of the ever-evolving nature of parasitic infections. The emergence of triclabendazole resistance in Fasciola hepatica, like a desert sandstorm, poses a significant threat to livestock and human health. The researchers call for a comprehensive approach, including integrated parasite management strategies, to combat this formidable challenge.

Date :
  1. Date Completed 2017-06-20
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27049013

DOI: Digital Object Identifier

10.1016/j.pt.2016.03.002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.